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Background and Objectives: Emerging research supports virtual reality (VR) use with people 
with dementia in the community, but is limited to this area, warranting further investigation in 
different environments. The feasibility of VR within an inpatient psychiatric care setting was 
therefore explored.  
Research Design and Methods: Eight people with dementia and sixteen caregivers were 
recruited in January and February 2018 from a UK hospital specialising in progressive 
neurological conditions. A mixed methods design measured affect and behaviour using the 
Observed Emotion Rating Scale, Overt Aggression Scale-Modified for Neurorehabilitation and 
St Andrew’s Sexual Behaviour Assessment. Thematic analysis was conducted following semi-
structured interviews. Caregivers who worked at the hospital supported people with dementia 
throughout the process and were interviewed for their views on Head Mounted Display-Virtual 
Reality (HMD-VR) use with people with dementia.  
Results: HMD-VR was tried and accepted by people with dementia. Participants viewed 
HMD-VR positively as a ‘change in environment’ and would use it again. People with 
dementia experienced more pleasure during and after HMD-VR compared to before exposure, 
as well as increased alertness after. Three core themes emerged: ‘Virtual Reality Experiences’, 
‘Impact of Virtual Reality’ and ‘Experiences within the Virtual Environment’. Caregivers 
discussed preconceptions about VR use and how these changed.   
Discussion and Implications: This is the first study to explore the feasibility of HMD-VR 
with people with mild to moderately severe dementia in hospital, and found that overall HMD-
VR is viable.  Findings evidence the clinical feasibility of HMD-VR implementation in this 
environment and inform future research.  
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Bringing the Outside In: The Feasibility of Virtual Reality with People with Dementia 
in an Inpatient Psychiatric Care Setting  
There are an estimated 850,000 people with dementia1 in the UK (Prince et al., 2014), 
9.4 million people with dementia in the US and 50 million people with dementia worldwide 
(Alzheimer’s Disease International, 2018). The National Dementia Strategy (Department of 
Health, 2009) set out to improve quality of life (QoL), with three key objectives: improved 
awareness; earlier diagnosis and intervention; and higher quality of care. Cameron’s Challenge 
on Dementia (Department of Health, 2012) later identified ‘better research’ as one of three key 
commitments. In line with the strategy objectives, Banerjee explored the prescription of 
medication for dementia and found antipsychotics for the treatment of behavioural disturbances 
to be overprescribed (Banerjee, 2009), ineffective and causing unwanted side effects including 
sedation and respiratory problems (Banerjee et al., 2011). The Department of Health (2009) 
supported Banerjee’s recommendation that best practice considers the use of pharmacological 
interventions only as a last resort to treat complex cases where non-pharmacological 
interventions have proven unsuccessful. The increasing prevalence of dementia further drives 
the need to continue to deliver excellent care and strive towards developing innovative 
interventions that support, manage and enhance QoL. 
A number of non-pharmacological interventions  aim to improve QoL (Spector et al., 
2003; Aguirre et al., 2013) and cognition of people with dementia (Logson, McCurry & Terri, 
2007; Woods, Aguirre, & Orell, 2012), as well as reduce  behavioural disturbance (Mapelli, 
Rosa, Nocita, & Sava, 2013). These include reminiscence, relaxation, life story work, music 
and cognitive stimulation therapy within a person centred therapeutic milieu (Brechin, Murphy, 
James, & Codner, 2013).  
The use of gaming technology including virtual reality (VR) has also entered the world 
of healthcare and in recent years low cost consumer-facing immersive VR systems have 
become widely available (e.g. Google Cardboard, Gear VR, Oculus Rift2). VR is a term used 
to describe the combination of software and hardware that simulates a 360° virtual environment 
(VE), allowing the user to engage in a three-dimensional computer generated environment, or 
360° video footage. Depending on the programmed complexity, the user can immerse in the 
                                                          
1 The term ‘people with dementia’ is used throughout in line with the DEEP Guidelines.  
2 https://store.google.com/product/google_carboard, www.samsung.com/global/galaxt/wearables/gear-vr , 
www.oculus.com 




virtual world by looking around, walking through, manipulating objects or performing a series 
of actions (Weiss, Kizony, Feintuch, & Katz, 2006). VR has been successfully used 
therapeutically, including pain management, physical rehabilitation and psychotherapy 
(Matsangidou, Ang, & Sakel, 2017; Matsangidou, Ang, Mauger, Otkhmezuri, & Tabbaa, 2017; 
Morris, Louw, & Grimmer-Somers, 2009; Riva, 2005), and for phobias (Rothbaum et al., 
1995).  
People with dementia have been involved in research that has explored the feasibility 
of VR, including both semi-immersive3 (Flynn et al., 2003; Siriaraya & Ang, 2014; Manera et 
al., 2016; Moyle, Jones, Dwan, & Petrovich, 2017) and fully-immersive4 systems (Mendez, 
Joshi, & Jimenez, 2014). The existing literature-base indicated that VR (although conclusions 
complicated by varying levels of immersion) can be feasible for people with ‘mild to moderate’ 
dementia (Manera et al., 2016) and in one case, people at ‘moderate to later’ stages (Moyle et 
al., 2017) living in the community or residential homes, with it being viewed as a welcomed 
distraction that increases alertness and pleasure. Nevertheless, there was evidence of adverse 
effects, specifically increases in fear and anxiety (Moyle et al., 2017) and the experience of 
negative memories (Siriaraya & Ang, 2014). Moyle et al. (2017) reported that caregivers felt 
the level of cognitive impairment of people was a variable that affected the experience, with 
VR not being stimulating enough for those within the early stages of dementia. Some caregivers 
observed VR to be more stimulating with people in the moderate to later stages where some 
people were observed to become bored, whilst other caregivers perceived the experience to be 
confusing for people in the later stages (see Rose et al. 2018).  
More research is required to explore the feasibility of VR in later stages of dementia, 
particularly in environments beyond the community where behaviour that challenges is not 
uncommon. The current study evaluated VR use with people with dementia in an inpatient 
psychiatric care setting, and explored the impact on wellbeing and behaviour. In addition to 
replicating previous positive effects, it was anticipated that engagement with VR would reduce 
behaviour that challenges and increase wellbeing for people with any stage of dementia.  
 
                                                          
3 A semi-immersive system has a graphical display which is projected on a large screen. 
4 A fully-immersive system is a Head Mounted Display system where the users’ vision is fully enveloped.  
 




Design and Methods 
Design 
A mixed methods design was used to collect data over a two month period, including 
observations and semi-structured interviews. Participants were recruited from an inpatient 
psychiatric care setting specialising in patients with progressive neurological conditions who 
may present with behaviour that challenges and/or offence-related risk. Ethical approval was 
sought from the hospital ([21]) as well as the London - Camden and Kings Cross Research 
Ethics Committee (17/LO/1477). Written informed consent forms were completed by 
participants. Where concerns were expressed with regards to an individual’s capacity to 
consent, capacity assessments were completed. The consent process was carried out in line 
with the Mental Capacity Act (2005), inviting a relevant consultee to consider providing 
consent on behalf of the person.  
Sample 
The inpatient psychiatric hospital delivers a variety of specialist therapies designed to 
reduce behaviour that challenges and encourage positive life experiences. Referrals are made 
nationally because of high levels of risk not easily met by local NHS provision. Patients are 
extremely complex, potentially combining cognitive, physical, psychiatric and forensic needs.  
A total of 153 people were screened for inclusion. Presence of aggression and/or 
inappropriate sexual or overfamiliar behaviour was not a direct inclusion criteria, however, 
people in the care setting presented with periodic behaviour that challenges..  Fifty-one people 
were identified as having dementia. After the exclusion criteria, the total eligible sample 
included 38 people with dementia. Exclusions included: epilepsy (n=5); multidisciplinary 
team’s (MDT) clinical judgement (n=5); visual impairment (n=1); imminent discharge (n=1); 
death (during selection process, n=1). There were no exclusions on the basis of motion 
sickness. Of those individuals deemed to have capacity to consent to their participation (n=8), 
six individuals consented and two declined. Of those who required an assessment to explore 
their capacity to consent to their participation (n=30), 12 capacity assessments were not 
completed by the MDTs due to time constraints. The remaining 18 individuals were found to 
lack capacity. For these individuals, a potential consultee was contacted to consider consent to 
participate on their behalf (next of kin or an advocate). A total of 13 consultees did not respond 
and three consultees declined consent to be approached. Two consultees gave consent to be 




approached and finally consent to participate. Therefore, the final sample included six 
individuals who consented to participate and two individuals with consultee consent.  
Twenty-four participants (8 people living with dementia, 16 caregivers) were recruited. 
The mean age for people with dementia was 69.63 years (range=41-88 years). The mean Global 
Deterioration Scale rating (GDS: Resiberg, Ferris, DeLeon, & Crook, 1982) completed by the 
treating MDT was 5/7 “moderate” (range=2-6: “mild to moderately severe”). Once recruited, 
people with dementia did not report to have previously used HMD-VR, although this was not 
part of the criteria. Caregivers were staff supporting people with dementia in the care setting 
(see Tables 1 and 2).  
Table 1. People with dementia demographics 
 People with dementia (n=8) 
 Frequency 
Age 69.63 (41-88) a 
    35-44 1 
    45-54 0 
    55-64 2 
    65-74 1 
    75-84 3 
    85-94 1 
Gender  
    Male 6 
    Female 2 
Primary diagnosis   
    Alzheimer’s disease 2 
    Unspecified Dementia 2 
    Dementia in Huntington’s disease 2 
    Mixed Cortical and Subcortical Vascular Dementia 1 
    Frontotemporal Dementia 1 
Secondary diagnosis  
    Recurrent Depressive Disorder 3 
    Depressive Episode 1 
    Organic Mood Disorder 1 




    Paranoid Schizophrenia 1 
Global Deterioration Scale rating (GDS) 5 (2-6) a 
1 No cognitive decline  0 
2 Very mild cognitive decline (age associated memory impairment) 1 
3 Mild cognitive decline (mild cognitive impairment) 0 
4 Moderate cognitive decline (mild dementia) 2 
5 Moderate severe cognitive decline (moderate dementia) 4 
6 Severe cognitive decline (moderately severe dementia) 1 
7 Very severe cognitive decline (severe dementia)  0 
Note: aMean (range).  
Table 2. Caregiver professions  
Professions   
    Nursing 11 
    Occupational Therapy 3 
    Psychology 1 
    Physiotherapy 1 
Registered/unregistered caregiver   
    Registered 3 
    Unregistered  13 
 
Materials 
For 360° video playbacks, a mobile Head Mounted Display, Samsung Gear VR with 
Samsung Galaxy S6 mobile phone (HMD-VR) was used to stream audio and visual content 
(see Figure 1). It allowed the participant to be fully-immersed by controlling the viewing 
direction by rotating their head as they would normally in the physical world. Virtual 
Environments  were used in the form of 360° video, also known as immersive or spherical 
videos, where video recording uses a omnidirectional camera (such as Ricoh Theta S5 and 
Samsung Gear 360°6) to capture a view in every direction.. The HMD-VR digital content was 
streamed to an external flat screen which allowed caregivers to see what the person with 








dementia was seeing and provide relevant prompts and reassurance during the exposure. A 
dictaphone was used for audio recording interviews and a video recorder to film people with 
dementia engaging in HMD-VR. Capacity was assessed using the hospital’s ‘Mental Capacity 
Act 2005 Assessment Checklist’ (see Supplementary Appendix 1).  
 
Figure 1: Samsung Gear VR. 7 
Procedure  
People with dementia were invited to use HMD-VR, with a familiar caregiver in a 
familiar room on the ward. They were offered a ‘menu’ of five VE’s to choose from (forest; 
countryside; sandy beach; rocky beach; cathedral, see Figure 2). People with dementia were 
offered a maximum of 15 minutes of HMD-VR exposure, viewing the VE(s) using the headset. 
Exposure time was consistent with Moyle et al. (2015) and selected to reduce the risk of side 
effects.  A technical researcher managed the equipment whilst a clinical researcher instructed 
the patient how to wear and use the headset. The caregiver directed the patient’s attention to 
the VE as mirrored on the flat screen. Patient’s interactions with HMD-VR were video recorded 
for later evaluations by the clinical researcher (OERS; OAS-MNR; SASBA; time exposed). 
After HMD-VR exposure patient’s completed a semi-structured interview. In addition to the 
HMD-VR exposure, a clinical researcher observed patient’s 15 minutes before their invitation 
to take part and 15 minutes following the interview, in care as usual.  Caregivers were invited 
to try the headset, for up to five minutes, following the observation of the person with dementia 
                                                          
7 https://www.samsung.com/uk/wearables/gear-vr-r322/ 




and engaged in a semi-structured interview. A second session of HMD-VR two weeks later 
was offered using the same procedure with a different caregiver. 
 
Figure 2: Still images of VE’s offered to participants.  
Data collection    
Quantitative data was collected by a clinical researcher, who was experienced in using the 
following measures:          
1. Overt Aggression Scale-Modified for Neurorehabilitation (OAS-MNR; Alderman, 
Knight & Morgan, 1997). Used routinely in the care setting, the scale offers continuous direct 
observation and assessment of antecedents, contexts, behaviours and interventions. It records 
the type and severity of aggression from four categories: verbal aggression, physical aggression 
against objects; physical aggression against self; physical aggression against others.  In relation 
to reliability, Alderman et al. reported Kappa values from 0.638 (substantial agreement) to 
1.000 (almost perfect agreement). 




2. St Andrews Sexual Behaviour Assessment (SASBA; Knight, Alderman, Johnson, 
Green, Birkett-Swan & Yorston, 2008). Used routinely in the care setting, the scale measures 
in the same way as the OAS-MNR but captures inappropriate or overfamiliar behaviour across 
four categories: verbal comments; non-contact; exposure; touching others. Knight et al reported 
Kappa values from 0.41 (moderate agreement) to 0.94 (almost perfect agreement).  
3. Observed Emotion Rating Scale (OERS; Lawton, Van Haitsma & Klapper, 1999). Used 
routinely in the care setting, the scale offers direct observation of the time spent expressing five 
affect types: pleasure; anger; anxiety; sadness; and general alertness. The tool was used for the 
duration of the HMD-VR exposure as determined by the participation (maximum of 15 
minutes). This was in order to maximise the richness of the data. Kappa values range from 0.76 
(substantial agreement) to 0.89 (almost perfect agreement) (Landis & Koch, 1977). 
4. Time. Participants could choose to spend up to 15 minutes exposed to HMD-VR. Time 
exposed was measured in minutes and seconds.   
Semi-structured interviews (see Supplementary Appendix 2) were conducted by two 
researchers. The schedule explored the ‘technology acceptance’ of HMD-VR, using a 
combination of the Usability Evaluation in Industry Questionnaire (Brooke, 1996) and 
‘presence’ using the Presence Questionnaire (Nichols, Haldane, & Wilson, 2000). Questions 
were also included that reflected the emotional effects of using HMD-VR. Caregivers engaged 
in the same interviews, but the aim was to reflect on their observations of the person with 
dementia using HMD-VR and seek professional opinions about the usability of HMD-VR in 
the inpatient environment. 
Interviews were transcribed verbatim by two researchers and analysed using thematic 
analysis (Braun & Clarke, 2006). The analysis aimed to provide a detailed account of a group 
of themes within the data, driven by our specific research question and using a theoretical 
thematic analysis.  Themes were identified at the semantic level, with a focus on explicit 
meanings of the data. Analysis and interpretation was guided by an essentialist epistemology, 
assuming a largely unidirectional relationship between meaning and experience and language. 
Familiarisation with data and manual generation of initial codes was completed by the clinical 
and technical researchers. One transcript was coded simultaneously by the two and discussed 
to explore congruency. Searching for initial themes was conducted by the same two 
researchers. Reviewing, and then defining and naming themes was completed by all 
researchers. The ‘keyness’ of each theme was determined in relation to the overall question of 




feasibility of HMD-VR, with prevalence regarded at the level of the data item (i.e. did the 
theme appear anywhere) as well as considering the entire data set.  
Results 
A range of sources of data were analysed. As can be seen from the results detailed 
below, there was great congruency in the positive acceptability of HMD-VR use by people 
with dementia. 
Observed emotions  
Friedman test indicated that ratings of pleasure significantly differed between before 
(Mdn=1.250), during (Mdn=2.000) and after (Mdn=1.750) HMD-VR exposure, χ2 (2) = 8.000, 
p = 0.018. Wilcoxon signed-rank tests revealed a significant increase in pleasure from before 
(Mdn=1.250) HMD-VR to during (Mdn=2.000) HMD-VR exposure Z= -2.060, p=0.039 and 
from before (Mdn=1.250) to after (Mdn=1.750) HMD-VR exposure Z= -2.060, p=0.039. There 
was no significant difference between during (Mdn=2.000) and after (Mdn=1.750) HMD-VR 
exposure (p=0.285 n.s).  
There was no significant difference in ratings of anger (p=1.000 n.s), anxiety/fear 
(p=0.212 n.s) or sadness (p=0.229 n.s) before, during and after HMD-VR exposure. 
 Ratings of general alertness significantly differed between before (Mdn=4.500), during 
(Mdn=5.000) and after (Mdn=5.000) HMD-VR exposure, χ2 (2) = 6.300, p = 0.043. Wilcoxon 
signed-rank tests revealed a significant increase in general alertness from before (Mdn=4.500) 
to after (Mdn=5.000) HMD-VR exposure Z= -2.060, p=0.039. There were no significant 
differences between before (Mdn=4.500) and during (Mdn=5.000) HMD-VR exposure 
(p=0.236 n.s) or during (Mdn=5.000) and after (Mdn=5.000) HMD-VR exposure (p=0.414 n.s) 
(Table 3; Figure 3). 
Table 3. Observed ratings of emotions before, during and after VR exposure using OERS. 
Affect p   m Mdn Phase p 
Pleasure 0.018 
Before 1.313 1.250 Before-during 0.039 
During 1.813 2.000 Before-after 0.039 
After 2.125 1.750 During-after 0.285 
Anger 1.000 
Before 1.063 1.000 Before-during 1.000 
During 1.063 1.000 Before-after 1.000 




After 1.063 1.000 During-after 1.000 
Anxiety/fear 0.212 
Before 1.938 1.750 Before-during 0.104 
During 1.250 1.000 Before-after 0.236 
After 1.625 1.250 During-after 0.102 
Sadness 0.229 
Before 2.313 1.250 Before-during 0.102 
During 1.438 1.000 Before-after 0.221 
After 1.625 1.000 During-after 0.414 
Alertness 0.043 
Before 4.000 4.500 Before-during 0.236 
During 4.500 5.000 Before-after 0.039 
After 4.688 5.000 During-after 0.414 
 
 
Figure 3: Median observed ratings of emotions before, during and after HMD-VR exposure 
using the OERS. 
 
 




Time spent exposed to HMD-VR  
A Wilcoxon signed-rank test demonstrated that there were no significant differences 
between people for time spent exposed to HMD-VR from the first session of exposure 
(Mdn=13:30) to the second session (Mdn=15:00) Z = -1.483, p = 0.138 (Figure 4).  
Figure 4: Total HMD-VR exposure time. 
Behaviour that challenges  
A total of 9 behaviours were observed and recorded (8=OAS-MNR; 1=SASBA). See 
Figure 5 for changes in frequency of observed behaviours and aggregate aggression scores 
(AAS).  





 Figure 5: Frequency of OAS-MNR and SASBA and OAS-MNR AAS before, during and 
after HMD-VR exposure. 
Interviews  
Thematic analysis revealed three core themes and eight subthemes embedded 
throughout the interviews. People with dementia and caregivers talked about ‘Virtual Reality 
Experiences’, ‘Impact of Virtual Reality’ and ‘Experiences within the Virtual Environment’. 
Only the caregivers discussed preconceptions they had of HMD-VR use with people with 
dementia.  
‘Virtual Reality Experiences’. Three subthemes were discovered in relation to the 
HMD-VR experience: technology acceptability; opportunities generated; individual 
preferences. 





Figure 6: People with dementia and caregiver themes.  
 
 Technology acceptability. Caregivers reported on preconceptions they had of using 
HMD-VR with individuals they supported. Caregivers thought it could be difficult for people 
with dementia to try new technology, and have the headset over their eyes, due to their older 
age and cognitive deficits. Caregivers were unsure whether people with dementia would try 
HMD-VR at all. Caregivers initially thought that HMD-VR was more suitable for younger 
people who they thought may know more about technology. They also thought that variables 
including cognitive impairment may impact acceptance. Caregivers were surprised that some 
people engaged for the entire HMD-VR session and that it was accepted by patients, including 
those who could present with aggression. Caregivers reported that their observations of the 
session changed their views on HMD-VR and they were more open to using it within the setting 
(Extract 1).   
Extract 1 
“with the experience I’ve got today I think that, every new thing is still good to try 
because… we cannot say it can’t work if we don’t try it and I saw it in the patient 
today I can see a bit of the benefit of that [HMD-VR] for a patient” [CG5, 6, 102-
1068].  
                                                          
8  PWD=person with dementia or CG=caregiver; interview number; page number; line number(s).      




People with dementia provided feedback on usability of HMD-VR technology, sharing 
that, “it was comfortable on my head” [Extract 2, PWD10, 3, 47] and easy to use which 
included putting the headset on and looking around whilst wearing it. They did not report 
experiencing any lag in the visual content and liked the fact they could look around the VE. 
PWDH thought, however, that HMD-VR did “not feel natural”. Nevertheless, participants’ 
preferences differed, with people with dementia favouring HMD-VR in comparison to 
conventional television as well as favouring television.  
Opportunities generated. Initially caregivers questioned why they could not take 
people outside rather than offering HMD-VR. Caregivers also considered that people might 
subsequently want to go to the VE in reality but their hospital leave could be restricted. 
Caregivers also viewed HMD-VR as a positive opportunity for people unable to access certain 
environments in reality. Broadly, both caregivers and people with dementia viewed HMD-VR 
as a tool that created opportunities including a change of environment and routine (Extract 3). 
Extract 3 
“You can’t get them to a forest walk every day, you can’t get them to a beach every 
day, you can’t get them to a cathedral every day and it’s as close to those 
environments that they can then get to regularly. Um so it’s… definitely beneficial 
for them because I mean [PWD] wouldn’t have seen the lovely countryside today 
if it hadn’t of been virtual reality unfortunately… so it’s great. It stimulated him.” 
[CG4, 1-2, 13-19]. 
 Caregivers reported that people with dementia were looking forward to using HMD-VR 
and engaged well in sessions. They also reported that HMD-VR had a positive impact on 
wellbeing after the session and it motivated people to want to go outside. Caregivers reported 
that from observing the session they discovered new skills and interests of the person with 
dementia, and felt they could reconsider their participation in other activities due to the success 
of the session. People with dementia reported that they found HMD-VR “fun” and “quite 
exciting…you never know what’s beyond the corner, do you?” [Extract 4, PWD13, 4, 79-80].  
PWD5 thought HMD-VR would be a good way to see what going abroad might be like, 
“because if you’re going abroad, all you get is a video of what’s going to be like” [Extract 5, 
PWD5, 108-109] or to trigger a memory they would not have otherwise experience. HMD-VR 
was also viewed as a new experience and an opportunity to pass the time whilst being in 
hospital (Extract 6). 





“Well for someone stuck in a hospital, you know, time drags, so, if we put those 
video things on…it gets you out of the place” [PWD5, 7, 134 & 140].  
Individual preferences. Caregivers explained that they were initially unsure of 
how people with dementia would react to HMD-VR and felt they would be sceptical 
about using HMD-VR. Caregivers reported that they liked HMD-VR and reported it was 
“interesting”, “intriguing”, and “exciting”.  However, they reported that they observed 
the engagement between the first and second session to differ and concluded that the 
benefits and reaction to HMD-VR could be individual (Extract 7).  
Extract 7 
“You might have different reactions from patient A to patient Z…you might have 
30 people and 25 of them might like that idea but 5 of them might not” [CG8, 6, 
109-111]. 
People with dementia reported they liked HMD-VR: “I loved it!” [Extract 8, PWD6, 3, 
51]. They broadly thought it was a “good idea” and expressed they would continue using 
HMD-VR. People with dementia were also excited in anticipation of their next 
opportunity to use HMD-VR and wanted to talk about their experience with others. 
PWD8 and PWD2 were initially disinterested in using HMD-VR again, although 
consented to re-try it. Both enjoyed the second experience and requested future 
opportunities.  Caregivers observed people with dementia enjoying using HMD-VR 
(Extract 9). 
Extract 9 
“I think she clearly really enjoyed it… she was smiling, she seemed really relaxed. 
Yeah she seemed to really enjoy it” [CG15, 2, 26-27]. 
 ‘Impact of the Virtual Reality’. There were three subthemes found that related to the 
impact of HMD-VR: emotional responses; physical and cognitive effects; memories evoked.   
Emotional responses. Caregivers held preconceptions about the emotional impact 
HMD-VR could have on people with dementia, which included potential distress or agitation 
as well as the potential experience of negative emotions from reminiscence triggered by the 




VE. They also reported that people could find being in the VE “lonely” or “scary”. Contrary to 
expectations, caregivers observed individuals to be calm when using HMD-VR and “it relaxed 
him at the time” [Extract 10, CG11, 1, 14]. People with dementia also commented on the 
emotional responses they themselves experienced when using HMD-VR. PWD10 reported 
feeling sad: “[be]cause I couldn’t see the birds I was sad” [Extract 11, PWD10, 4, 74].  Others 
reported feeling “calm” and “relaxed” as well as “excited” and “happy”. PWD12 reported 
feeling “good” and “I feel excellent…. I can’t describe it” [Extract 12, PWD12, 6, 109 & 111] 
after using HMD-VR. PWD4 reported “I felt quite emotional” [Extract 13, PWD4, 3, 205] and 
was visibly moved, verbally describing a “happy” emotion.     
Physical and cognitive effects. Caregivers also shared their preconceptions around the 
physical and cognitive effects HMD-VR could cause, specifically potential for disorientation, 
perseveration and confusion, as well as standing and/or falling whilst using the headset. People 
with dementia were prompted to reflect on the physical impact of using HMD-VR and shared 
that HMD-VR did not make them feel tired or dizzy. This was also observed by the supporting 
caregivers. Nonetheless, PWD4 reported feeling tired and PWD16 reported feeling dizzy from 
using HMD-VR.   A caregiver observed short-term disorientation in PWD7 after using HMD-
VR.   
 Memories evoked. Whilst using HMD-VR and after exposure, people with dementia 
reminisced positively about topics including family, geographical origins and travels. People 
with dementia reported the VE looked like a familiar place and that “it reminds me of the old 
days” [Extract 14, PWD13, 6, 113]. Caregivers also identified a process of reminiscence. On 
the second HMD-VR exposure, people with dementia both recalled their first experience as 
part of the study and forgot. Caregivers also reported that people remembered the first exposure 
two weeks prior. 
‘Experiences within the Virtual Environment’. In relation to the VE, two sub-themes 
were generated: immersion and content preferences. 
Immersion.  It was harder for people with dementia who spent less time in HMD-VR 
to assess whether they were immersed. Of those who chose to spend longer, when asked about 
whether HMD-VR felt ‘real’, they reported that HMD-VR felt “real” and they felt like they 
were “in” the VE (Extract 15).   
Extract 15 




“I felt like I was in the beach… it was very good feeling” [PWD4, 7, 141 &144].  
 Caregivers reported that HMD-VR “felt real”.  CG4 reported “you feel like you’re 
within it I guess. You can’t see the room that you’re actually in, so you are in that picture” 
[Extract 16, CG4, 3, 48-49]. Caregivers felt the people they were supporting were immersed in 
the VE, and HMD-VR could make people “think they’ve been somewhere because they’ve got 
this little time, and some relaxation” [Extract 17, CG14, 8, 175-176]. They explained that the 
effects of being immersed could be positive for people with dementia. Caregivers only spent a 
short time trying HMD-VR (a maximum of 5 minutes) and surmised that the amount of time 
spent using HMD-VR could affect the feeling of immersion. Consequently, caregivers also 
reported immersion was not achieved. For example, CG02 reported being aware of their 
surroundings (although, commented they did not mind others being present).  
Content preferences. Preferences relating to the VE content were provided by people 
with dementia and caregivers. CG16, had a preconception that a particular VE would be loved 
by the person with dementia they supported. Caregivers observed people exploring the VE by 
moving their heads as well as verbalising their real time experiences. People with dementia 
were both able and unable to communicate a particular VE preference. They indicated that they 
liked the VEs offered and described comparisons between the VEs and the real world. During 
interviews, people with dementia described elements within the VE (Extract 18) and found 
exploring the VE “exciting” and “interesting”. 
Extract 18 
 “You can see all the trees and that and the conifers, different colour conifers” 
[PWD5, 1, 8-9].  
When asked specifically, people with dementia commented on enjoying the VE sounds, 
including “you hear the choir, and everything. And umm, it was quite a good experience” 
[Extract 19, PWD13, 7,137-138). However, people with dementia also did not find the VE 
interesting and did not like the sounds. When giving feedback, memory was also a factor, with 
people commenting that they could not recall either certain elements in the VE or the sounds. 
Discussion 
HMD-VR has the advantage of creating a naturalistic VE which provides opportunities 
that may be difficult to achieve or inaccessible (Siriaraya & Ang, 2014). This could be due to 




ill health, a place of interest or artefact no longer existing, or someone being restricted under 
the Mental Health Act. HMD-VR can also be implemented immediately after invitation to 
participate.  In addition, HMD-VR has the potential to provide care that is wholly consistent; 
if a person enjoys a particular VE they have the opportunity to revisit it without the risk of 
extraneous variables such as weather or caregiver accessibility. The purpose of the study was 
to explore whether HMD-VR use was feasible with people with moderate to severe dementia 
who reside in an inpatient psychiatric care setting. Despite the broad patient group, difficulties 
were faced in accessing more participants with severe cognitive impairment. This was largely 
due to the lengthy process of assessing capacity which relied on busy MDTs and seeking 
consent from potential consultees, many of whom relied on postal correspondence. The study 
consequently included participants with mild to moderately severe cognitive impairment within 
the context of dementia.   
Contrary to caregiver’s reported expectations,  people with dementia tried the HMD-
VR, and the time engaged in HMD-VR increased from the first to the second exposure albeit 
not statistically significantly (although likely due to HMD-VR use towards the maximum time 
offered during the first exposure). With regards to behaviour that challenges, analysis was 
limited due to the small number of behaviours observed in total. Interestingly however, 
behaviours occurred only around the first HMD-VR exposure timeframe. Overall, the HMD-
VR experience had a positive impact upon people with dementia, with significant 
improvements observed from before to after HMD-VR exposure in pleasure and alertness, as 
well as before to during HMD-VR exposure for pleasure. The current study found no adverse 
effects in the form of fear/anxiety, sadness and anger. 
Qualitative analysis explored the reported experiences of using HMD-VR from the 
perspective of the people with dementia and the caregivers supporting them.  Participants 
talked about their HMD-VR experience in relation to technology acceptance, the opportunities 
generated for user wellbeing, and the importance of individual preferences. The impact of the 
HMD-VR exposure was also discussed in relation to the emotional responses of people with 
dementia along with the physical and cognitive effects and the memories evoked. Lastly, in 
relation to the VE, participants reported on their experiences of immersion and actual content. 
Caregivers also expressed preconceptions about HMD-VR use with people with dementia and 
how these changed following the exposures. Prior to exposure, caregivers referred to the level 
of cognitive impairment as a factor that could potentially impact on unfamiliar technology 
acceptance. However, much to their reported surprise, people with dementia all tried HMD-




VR and most used the maximum amount of time offered. The VEs were typically viewed 
positively, however a minority commented on wanting more time within the VE. Individual 
differences were a prominent theme, with some people with dementia preferring alternative 
technology (including television) over HMD-VR, although still expressing interest in trying 
HMD-VR again. One person’s negative views changed a fortnight later when offered the 
second opportunity, when they then requested repeat exposure.   
In terms of the usability of HMD-VR technology, we took into consideration the 
evaluations of both Moyle et al. (2017) and Siriaraya and Ang (2014) in that participants were 
seated, and the experience did not require a lot of physical interaction. This was a strength of 
the design, reducing risk of fatigue or discomfort. We used a mobile HMD that provided visual 
and audial feedback and were interested in whether people with dementia would be content to 
wear it. Using a wireless mobile HMD allowed flexibility in setting up the equipment quickly 
and unobtrusively in different familiar locations, allowing caregivers to easily focus on 
introducing the equipment and supporting the person.  
We were also interested to further explore affect, including fear and anxiety, as had 
been previously recommended. Participants were offered a choice of five VEs and were 
supported by familiar staff to promote a person centred approach. This was a strength of the 
research design and may have contributed to the positive experience observed overall.  
Limitations of the current study 
The sample was relatively small and restricted to a single inpatient setting, limiting 
generalisability of findings. Nevertheless, important evidence about the feasibility of HMD-
VR technology use with a potentially challenging patient group has been demonstrated. These 
initial findings are particularly significant given the infancy of the research area. 
During data collection it was not always possible to observe the person directly before 
and after their exposure to HMD-VR due to circumstances beyond our control (e.g. the 
individual being supported with personal care). Therefore some behaviours or aspects of 
emotional presentation could not be captured on the observational tools. Further, ratings from 
the video recordings (during the HMD-VR exposure) could have been more accurate than 
ratings from observations conducted in real time as the timeframes could be re-watched. Inter-
rater reliability for the OAS-MNR, SASBA and OERS was not measured due to only one 
clinical researcher collecting data. This also opened the possibility for data bias. All three 




measures were familiar to the clinical researcher who was already trained for routine clinical 
practice.  
Challenges were faced when using the OERS. The tool measures time spent within each 
observed affect, which corresponds to a rated score. People who spent less than five minutes 
exposed to HMD-VR were therefore unable to score the maximum rating of ‘more than 5 
minutes’. Future research will need to accommodate this in order to measure the quality of 
shorter HMD-VR exposures. In addition, the data collected relating to ‘eyes’ on the OERS 
could not be rated due to the headset covering the patients’ eyes. Instead, the rater relied on 
additional indicators for each of the five affect types, including the upper face, nose and mouth, 
as well as posture, gross motor movement and verbal communication. 
Whilst visual impairment was an exclusion criterion, we did not test for hearing 
impairment and are unable to conclude whether hearing may have affected individuals’ HMD-
VR experience. Physical effects of HMD-VR were not formally measured in our study, a 
limitation that could be considered for future research. People with dementia either reported or 
were observed to find the HMD-VR exposure a positive experience; however one person 
reported feeling temporarily dizzy, but still reported they would try HMD-VR again.  It is worth 
nothing that the dizziness was reported in parallel to the headset being frequently moved to and 
from their eyes which may have contributed, as the selected headset was designed to be kept 
on. All other participants used the headset in the designed manner and did not report dizziness.  
Implications 
The current study supports previous findings exploring the use of HMD-VR technology 
by people with dementia (Moyle et al., 2017; Siriaraya & Ang, 2014; Manera et al., 2016; 
Mendez et al., 2014) and extends feasibility to people with more advanced dementia residing 
in an inpatient psychiatric care setting. The key issues regarding feasibility of HMD-VR that 
were worked through in the study are summarised in Table 4. HMD-VR was largely well 
received by people with dementia and their caregivers, opening up clinical implementations as 
a person centred intervention. Further, HMD-VR could provide opportunity for additional 
positive effects that might not be otherwise triggered, including subsequent reminiscence, 
promoting social interaction with others through sharing experiences, and inspiration to go 
outside.  
 








(2) Facilitation requirements 
 
(3) Problems observed 
 
Participants Assessment of mental capacity. Length of time required for 
assessment completion and 
difficulties liaising with 
consultees for potential 
participants lacking mental 
capacity. 
VR Hardware HMD-VR and a linked laptop to 
enable carer to support the 
interaction and use of the 
equipment. 
Some people with dementia 
preferring alternative 
technology (including 
television) over HMD-VR. 
Dizziness reported by a person 
who frequently moved the 
headset to and from their eyes. 
All others used the headset in 
the designed manner and did 
not report dizziness. 
VR Software (VEs) People with dementia were 
offered a choice of five neutral 
VEs and were supported by 
familiar staff to promote a 
person centred approach. 
The positive or negative effects 
may have been underplayed 
because the VE’s were not 
personalised.  
Distraction free and 
comfortable location  
Participants were seated, and 
the experience did not require a 
lot of physical interaction, 
reducing the risk of fatigue or 
discomfort. There were no 
environmental distractions 
noted. 
Unable to test feasibility in a 
busy shared environment. 





measures to monitor 
effects of exposure to 
HMD-VR and VEs 
Appropriate measures to 
address intervention goals:  
OAS-MNR, SASBA and OERS 
Insufficient frequencies of 
behaviour that challenges for 
the duration of study 
observations precluded valid 
statistical analysis. 
Unable to rate observations of 
affect specifically in relation to 
eyes due to HMD-VR headset 
covering the participants’ eyes. 
Due to care needs (e.g. personal 
care), after exposure 
observations were on occasion 
delayed. 
 
A number of learning points have been highlighted for consideration at clinical 
implementation level.  For example, the benefits of offering a menu choice of VEs. Further, 
considering the additional opportunities for customisation of VEs to an individual’s hobbies or 
interests, or specific personal environments.  We recommend the use of a programme that 
wirelessly mirrors the users’ real-time experience onto an external flat screen so caregivers can 
see what the user is experiencing. This allows carers to better support and interact with the 
person in real-time. Although the HMD-VR exposures within the research context were 
perceived to be generally positive, some caregivers still expressed concerns about using HMD-
VR clinically. This seemed to relate to the practicalities of using the technology within a 
hospital environment rather than its use with the patient group. We recognise that for some this 
could be a barrier to future clinical implementation.  The potential of devising clear technical 
and clinical guidelines or a package to support and encourage implementation could therefore 
be considered. We also recommend educating caregivers on HMD-VR in order to address any 
preconceptions and maximise technology acceptance.  
This study has explored the feasibility of the HMD-VR technology; however, in future 
research it would be interesting to explore the attributes of HMD-VR as a non-pharmacological 
person-centred intervention in comparison to ‘care as usual’, as well as comparison with other 
interventions already evidenced in national dementia practice guidelines. A larger scale study 
with multi sites could maximise potential participation and open up opportunity to explore 




variables such as: age; gender; level of previous exposure to technologies; type of dementia 
diagnosis; co-morbidities; stage of disease progression; symptom profiles including specific 
cognitive impairments, mood or behaviour that challenges. To begin with, participants 
suggested that specific VEs were associated with negative emotions because of missing visual 
cues (e.g. birds). In future research, further evaluation of VEs and levels of immersion could 
be sought, as well as exploring idiosyncratic preferences.  Taking into consideration that some 
people reported a preference for flat screen projection (i.e. television) in comparison to HMD-
VR, different types of VR systems could also be investigated to explore whether there is 
interaction between the impact of VR and the type of immersive system. Research could also 
explore whether or not the caregiver supporting the person with dementia had an impact on the 
HMD-VR experience; this was not measured in our study. This may be difficult to measure 
given that cognitive impairment means that VR without carer presence is likely to be 
unavoidable. In addition, it might also be interesting to explore if relatives have the same 
preconceptions as the caregiver participants were found to have. 
Additional considerations for future research methodology include: screening hearing 
impairment as part of the inclusion and exclusion criteria; use of a validated tool for measuring 
dizziness; improving accuracy of ‘before’ and ‘after’ ratings by video recording care as usual; 
accounting for inter-rater factors in relation to the observation tools; and analysing the 
interaction between the person with dementia, the caregiver and researcher and how these 
might impact on the experience as a whole. In addition, it would also be interesting to invite 
relatives to play more of an active role in research, beyond that of providing consent for those 
without capacity. Their involvement may have a positive impact on both the person with 
dementia’s engagement and experience of the HMD-VR.  
Future research involving people with dementia should also follow the Mental Capacity 
Act (2005) to maximise opportunity for participation at all stages of dementia. The act presents 
clear guidelines on the process of gaining consent with people who may lack capacity to 
consent. We adopted these guidelines, and inherently faced challenges in recruiting participants 
due to the lengthy process. We advise future projects consider inviting relatives to have the 
opportunity to play more of an active role in the research, which may subsequently attract more 
potential participants.  
 
 





The outcomes of the current study suggest that HMD-VR use is feasible for people 
living with a mild to moderately severe dementia, even those presenting with periodic 
behaviour that challenges and residing in hospital. This is exciting and innovative in terms of 
the implications for future clinical implementation. However, the therapeutic benefit of HMD-
VR compared to other person centred interventions and the potential for personalisation of VEs 
as well as refinement of available VR technologies still warrants further investigation.   
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